BIRSA 101, launched in November 2025, is India's first indigenous CRISPR-based gene therapy for:
- Ahaemophilia
- Bthalassaemia
- Cmuscular dystrophy
- Dsickle cell disease
Show answer and explanation
Correct answer: (d) sickle cell disease
Explanation
BIRSA 101 is named after Bhagwan Birsa Munda, since sickle cell disease affects many tribal people.